| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
AXIM Biotechnologies Inc (OTCQB: AXIM)
AXIM Technical Analysis
1
| As on N/A AXIM STOCK Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS. |
AXIMSTOCK Price
| Open | N/A | Change | Price | % |
| High | N/A | 1 Day | N/A | N/A |
| Low | N/A | 1 Week | N/A | N/A |
| Close | N/A | 1 Month | N/A | N/A |
| Volume | N/A | 1 Year | N/A | N/A |
| 52 Week High N/A | 52 Week Low N/A | ||||
OTCQB USA Most Active Stocks
| FNMAS | 10.12 | 2.33% |
| FMCKJ | 9.73 | 0.83% |
| BMIX | 0.01 | % |
| BTCWF | 0.10 | 150.00% |
| ALPP | 3.56 | 0.00% |
| ALPP | 3.56 | 0.00% |
| NWBO | 0.31 | -3.12% |
| VKIN | 0.23 | 0.00% |
| FNMA | 2.65 | 0.76% |
| LTSRF | 0.15 | -6.25% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| AXIM Daily Charts |
AXIM Intraday Charts |
Whats New @ Bazaartrend |
AXIM Free Analysis |
|
|
AXIM Important Levels Intraday
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE |
AXIM Forecast December 2024
| 4th UP Forecast | |
| 3rd UP Forecast | |
| 2nd UP Forecast | |
| 1st UP Forecast | |
| 1st DOWN Forecast | |
| 2nd DOWN Forecast | |
| 3rd DOWN Forecast | |
| 4th DOWN Forecast |
AXIM Weekly Forecast
| 4th UP Forecast | |
| 3rd UP Forecast | |
| 2nd UP Forecast | |
| 1st UP Forecast | |
| 1st DOWN Forecast | |
| 2nd DOWN Forecast | |
| 3rd DOWN Forecast | |
| 4th DOWN Forecast |
AXIM Forecast2024
| 4th UP Forecast | |
| 3rd UP Forecast | |
| 2nd UP Forecast | |
| 1st UP Forecast | |
| 1st DOWN Forecast | |
| 2nd DOWN Forecast | |
| 3rd DOWN Forecast | |
| 4th DOWN Forecast |
AXIM Biotechnologies Inc ( OTCQB USA Symbol : AXIM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AXIM Business Profile
AXIM Biotechnologies, Inc., a preclinical stage research and development company focuses on changing diagnosis and treatment for oncology and SARS-CoV-2 (COVID-19). The company is developing NeuCovix, a rapid diagnostic test measuring levels of functional neutralizing antibodies to prevent SARS-CoV-2 from entering the host cells; and ImmunoPass, a rapid serological diagnostic test that measures SARS-CoV-2 neutralizing antibodies within 10 minutes. It is also developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis; and SPX-1009, an anti-metastatic treatment to measure levels of quiescin sulfhydryl oxidase I. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is headquartered in San Diego, California. Address: 6191 Cornerstone Court, East, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service